Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene

Infection and Immunity

Volumn 77, Issue 9, 2009, Pages 4136-4149

  Goupil, Mathieu ^a   Trudelle, Émilie Bélanger ^a   Dugas, Véronique ^a   Racicot Bergeron, Catherine ^a   Aumont, Francine ^a   Sénéchal, Serge ^a   Hanna, Zaher ^a,c,d   Jolicoeur, Paul ^a,c,d   De Repentigny, Louis ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEF PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHORBOL 13 ACETATE 12 MYRISTATE; REV PROTEIN; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CD4-POSITIVE T-LYMPHOCYTES; CELL POLARITY; FEMALE; GASTRIC MUCOSA; HIV-1; HYDROGEN PEROXIDE; MACROPHAGES; MALE; MICE; MICE, INBRED C3H; MICE, TRANSGENIC; MOUTH MUCOSA; NITRIC OXIDE SYNTHASE TYPE II; PHAGOCYTOSIS; TRANSGENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69049085641     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00453-09     Document Type: Article

References (74)

1. Balish, E., H. Filutowicz, and T. D. Oberley. 1990. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect. Immun. 58:107-113.
2. Barker, K. S., T. Liu, and P. D. Rogers. 2005. Coculture of THP-1 human mononuclear cells with Candida albicans results in pronounced changes in host gene expression. J. Infect. Dis. 192:901-912.
3. Bergamini, A., F. Bolacchi, E. Faggioli, R. Placido, S. Vendetti, L. Cappannoli, L. Ventura, G. Cerasari, I. Uccella, M. Andreoni, and G. Rocchi. 1998. HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages. Clin. Exp. Immunol. 112:105-111.
4. Brown, G. D., J. Herre, D. L. Williams, J. A. Willment, A. S. Marshall, and S. Gordon. 2003. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197:1119-1124.
5. Brown, J. N., J. J. Kohler, C. R. Coberley, J. W. Sleasman, and M. M. Goodenow. 2008. HIV-1 activates macrophages independent of Toll-like receptors. PLoS ONE 3:e3664.
6. Campo, J., R. J. Del, J. Castilla, S. Garcia, C. Rodriguez, and A. Bascones. 2002. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J. Oral Pathol. Med. 31:5-10.
7. + lymphocytes in resistance to mucosal candidiasis. Infect. Immun. 59:2447-2455.
8. Cenci, E., L. Romani, A. Mencacci, R. Spaccapelo, E. Schiaffella, P. Puccetti, and F. Bistoni. 1993. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol. 23:1034-1038.
9. Chakir, J., L. Cote, C. Coulombe, and N. Deslauriers. 1994. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol. Immunol. 9:88-94.
10. Cole, G. T., A. A. Halawa, and E. J. Anaissie. 1996. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin. Infect. Dis. 22(Suppl. 2):S73-S88.
11. Conti, H. R., F. Shen, N. Nayyar, E. Stocum, J. N. Sun, M. J. Lindemann, A. W. Ho, J. H. Hai, J. J. Yu, J. W. Jung, S. G. Filler, P. Masso-Welch, M. Edgerton, and S. L. Gaffen. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206:299-311.
12. Coste, A., C. Lagane, C. Filipe, H. Authier, A. Gales, J. Bernad, V. Douin-Echinard, J. C. Lepert, P. Balard, M. D. Linas, J. F. Arnal, J. Auwerx, and B. Pipy. 2008. IL-13 attenuates gastrointestinal candidiasis in normal and immunodeficient RAG-2(-/-) mice via peroxisome proliferator-activated receptor-gamma activation. J. Immunol. 180:4939-4947.
13. Crowe, S. M., N. J. Vardaxis, S. J. Kent, A. L. Maerz, M. J. Hewish, M. S. McGrath, and J. Mills. 1994. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J. Leukoc. Biol. 56:318-327.
14. de Repentigny, L., F. Aumont, J. S. Ripeau, M. Fiorillo, D. G. Kay, Z. Hanna, and P. Jolicoeur. 2002. Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1. J. Infect. Dis. 185:1103-1114.
15. de Repentigny, L., D. Lewandowski, and P. Jolicoeur. 2004. immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin. Microbiol. Rev. 17:729-759.
16. Dickie, P., A. Roberts, and R. Lee. 2001. A defect in HIV-1 transgenic murine macrophages results in deficient nitric oxide production. J. Leukoc. Biol. 70:592-600.
17. Elahi, S., G. Pang, R. B. Ashman, and R. Clancy. 2001. Nitric oxide-enhanced resistance to oral candidiasis. Immunology 104:447-454.
18. Elahi, S., G. Pang, R. Clancy, and R. B. Ashman. 2000. Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect. Immun. 68:5771-5777.
19. + T lymphocytes in recovery from oropharyngeal candidiasis. Infect. Immun. 70:724-731.
20. Farah, C. S., S. Elahi, G. Pang, T. Gotjamanos, G. J. Seymour, R. L. Clancy, and R. B. Ashman. 2001. T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect. Immun. 69:6110-6118.
21. Farah, C. S., Y. Hu, S. Riminton, and R. B. Ashman. 2006. Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting. Oral Microbiol. Immunol. 21:252-255.
22. Farah, C. S., J. M. Saunus, Y. Hu, A. Kazoullis, and R. B. Ashman. 2009. Gene targeting demonstrates that inducible nitric oxide synthase is not essential for resistance to oral candidiasis in mice, or for killing of Candida albicans by macrophages in vitro. Oral Microbiol. Immunol. 24:83-88.
23. Fattorossi, A., R. Nisini, J. G. Pizzolo, and R. D'Amelio. 1989. New, simple flow cytometry technique to discriminate between internalized and membrane-bound particles in phagocytosis. Cytometry 10:320-325.
24. Federico, M., Z. Percario, E. Olivetta, G. Fiorucci, C. Muratori, A. Micheli, G. Romeo, and E. Affabris. 2001. HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. Blood 98:2752-2761.
25. Fidel, P. L., Jr. 2006. Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis. Adv. Dent. Res. 19:80-84.
26. Gordon, S. 2007. The macrophage: past, present and future. Eur. J. Immunol. 37(Suppl. 1):S9-S17.
27. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
28. Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
29. Hanna, Z., D. G. Kay, M. Cool, S. Jothy, N. Rebai, and P. Jolicoeur. 1998. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J. Virol. 72:121-132.
30. Hanna, Z., D. G. Kay, N. Rebai, A. Guimond, S. Jothy, and P. Jolicoeur. 1998. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95:163-175.
31. Howell, A. L., D. S. Groveman, P. K. Wallace, and M. W. Fanger. 1997. HIV-1-infected monocytes and monocyte-derived macrophages are impaired in their ability to produce superoxide radicals. Int. J. Clin. Lab Res. 27:111-117.
32. Hwang, M. N., K. S. Kim, Y. W. Choi, I. Jou, and S. Yoon. 2007. PMA activates Stat3 in the Jak/Stat pathway and induces SOCS5 in rat brain astrocytes. Mol. Cells 23:94-99.
33. Jensen, J., T. Warner, and E. Balish. 1994. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J. Infect. Dis. 170:900-905.
34. Jones-Carson, J., A. Vazquez-Torres, H. C. van der Heyde, T. Warner, R. D. Wagner, and E. Balish. 1995. Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat. Med. 1:552-557.
35. Kedzierska, K., R. Azzam, P. Ellery, J. Mak, A. Jaworowski, and S. M. Crowe. 2003. Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J. Clin. Virol. 26:247-263.
36. Kim, H. S., E. H. Choi, J. Khan, E. Roilides, A. Francesconi, M. Kasai, T. Sein, R. L. Schaufele, K. Sakurai, C. G. Son, B. T. Greer, S. Chanock, C. A. Lyman, and T. J. Walsh. 2005. Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect. Immun. 73:3714-3724.
37. + T cell phenotype and function determine the susceptibility to mucosal candidiasis in transgenic mice expressing HIV-1. J. Immunol. 177:479-491.
38. Lilly, E. A., D. J. Hart, J. E. Leigh, S. Hager, K. M. McNulty, D. E. Mercante, and P. L. Fidel, Jr. 2004. Tissue-associated cytokine expression in HIV-positive persons with oropharyngeal candidiasis. J. Infect. Dis. 190:605-612.
39. Liu, W. S., and C. A. Heckman. 1998. The sevenfold way of PKC regulation. Cell. Signal. 10:529-542.
40. Mangino, G., Z. A. Percario, G. Fiorucci, G. Vaccari, S. Manrique, G. Romeo, M. Federico, M. Geyer, and E. Affabris. 2007. In vitro treatment of human monocytes/macrophages with myristoylated recombinant Nef of human immunodeficiency virus type 1 leads to the activation of mitogenactivated protein kinases, IκB kinases, and interferon regulatory factor 3 and to the release of beta interferon. J. Virol. 81:2777-2791.
41. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093-8098.
42. + T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1. Infect. Immun. 74:2382-2391.
43. Marr, K. A., S. A. Balajee, T. R. Hawn, A. Ozinsky, U. Pham, S. Akira, A. Aderem, and W. C. Liles. 2003. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect. Immun. 71:5280-5286.
44. Martinez, F. O., A. Sica, A. Mantovani, and M. Locati. 2008. Macrophage activation and polarization. Front. Biosci. 13:453-461.
45. Martins, M. D., M. Lozano-Chiu, and J. H. Rex. 1998. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 27:1291-1294.
46. Mercante, D. E., J. E. Leigh, E. A. Lilly, K. McNulty, and P. L. Fidel, Jr. 2006. Assessment of the association between HIV viral load and CD4 cell count on the occurrence of oropharyngeal candidiasis in HIV-infected patients. J. Acquir. Immune Defic. Syndr. 42:578-583.
47. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969.
48. Muller, F., H. Rollag, and S. S. Froland. 1990. Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects. Clin. Exp. Immunol. 82:10-15.
49. Muller, U., W. Stenzel, G. Kohler, C. Werner, T. Polte, G. Hansen, N. Schutze, R. K. Straubinger, M. Blessing, A. N. McKenzie, F. Brombacher, and G. Alber. 2007. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol. 179:5367-5377.
50. Murciano, C., A. Yanez, M. L. Gil, and D. Gozalbo. 2007. Both viable and killed Candida albicans cells induce in vitro production of TNF-alpha and IFN-gamma in murine cells through a TLR2-dependent signalling. Eur. Cytokine Netw. 18:38-43.
51. Murciano, C., A. Yanez, J. E. O'Connor, D. Gozalbo, and M. L. Gil. 2008. Influence of aging on murine neutrophil and macrophage function against Candida albicans. FEMS Immunol. Med. Microbiol. 53:214-221.
52. Netea, M. G., K. Gijzen, N. Coolen, I. Verschueren, C. Figdor, J. W. Van der Meer, R. Torensma, and B. J. Kullberg. 2004. Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages. Microbes Infect. 6:985-989.
53. Netea, M. G., N. A. Gow, C. A. Munro, S. Bates, C. Collins, G. Ferwerda, R. P. Hobson, G. Bertram, H. B. Hughes, T. Jansen, L. Jacobs, E. T. Buurman, K. Gijzen, D. L. Williams, R. Torensma, A. McKinnon, D. M. MacCallum, F. C. Odds, J. W. Van der Meer, A. J. Brown, and B. J. Kullberg. 2006. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Investig. 116:1642-1650.
54. Netea, M. G., J. W. Meer, I. Verschueren, and B. J. Kullberg. 2002. CD40/ CD40 ligand interactions in the host defense against disseminated Candida albicans infection: the role of macrophage-derived nitric oxide. Eur. J. Immunol. 32:1455-1463.
55. Nielsen, H., K. D. Bentsen, L. Hojtved, E. H. Willemoes, F. Scheutz, M. Schiodt, K. Stoltze, and J. J. Pindborg. 1994. Oral candidiasis and immune status of HIV-infected patients. J. Oral Pathol. Med. 23:140-143.
56. Nielsen, H., A. Kharazmi, and V. Faber. 1986. Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome. Scand. J. Immunol. 24:291-296.
57. Nottet, H. S., L. de Graaf, N. M. de Vos, L. J. Bakker, J. A. van Strijp, M. R. Visser, and J. Verhoef. 1993. Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection. J. Infect. Dis. 168:84-91.
58. Noursadeghi, M., J. Tsang, R. F. Miller, S. Straschewski, P. Kellam, B. M. Chain, and D. R. Katz. 2009. Genome-wide innate immune responses in HIV-1-infected macrophages are preserved despite attenuation of the NFkappa B activation pathway. J. Immunol. 182:319-328.
59. Olivetta, E., Z. Percario, G. Fiorucci, G. Mattia, I. Schiavoni, C. Dennis, J. Jager, M. Harris, G. Romeo, E. Affabris, and M. Federico. 2003. HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation. J. Immunol. 170:1716-1727.
60. Pfaffl, M. W., G. W. Horgan, and L. Dempfle. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30:e36.
61. Pirofski, L. A., and A. Casadevall. 2009. Rethinking T cell immunity in oropharyngeal candidiasis. J. Exp. Med. 206:269-273.
62. Pugliese, A., D. Torre, F. M. Baccino, G. Di Perri, C. Cantamessa, L. Gerbaudo, A. Saini, and V. Vidotto. 2000. Candida albicans and HIV-1 infection. Cell Biochem. Funct. 18:235-241.
63. Romani, L. 1999. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr. Opin. Microbiol. 2:363-367.
64. Samaranayake, L. P., and P. Holmstrup. 1989. Oral candidiasis and human immunodeficiency virus infection. J. Oral Pathol. Med. 18:554-564.
65. Saresella, M., K. Roda, L. Speciale, D. Taramelli, E. Mendozzi, F. Guerini, and P. Ferrante. 1997. A rapid evaluation of phagocytosis and killing of Candida albicans by CD13+ leukocytes. J. Immunol. Methods. 210:227-234.
66. Schilling, D., K. Thomas, K. Nixdorff, S. N. Vogel, and M. J. Fenton. 2002. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. J. Immunol. 169:5874-5880.
67. Schroder, K., M. J. Sweet, and D. A. Hume. 2006. Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology. 211:511-524.
68. Vazquez-Torres, A., and E. Balish. 1997. Macrophages in resistance to candidiasis. Microbiol. Mol. Biol. Rev. 61:170-192.
69. Vazquez-Torres, A., J. Jones-Carson, and E. Balish. 1994. Candidacidal activity of macrophages from immunocompetent and congenitally immunodeficient mice. J. Infect. Dis. 170:180-188.
70. Vazquez-Torres, A., J. Jones-Carson, and E. Balish. 1996. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. Infect. Immun. 64:3127-3133.
71. Vazquez-Torres, A., J. Jones-Carson, T. Warner, and E. Balish. 1995. Nitric oxide enhances resistance of SCID mice to mucosal candidiasis. J. Infect. Dis. 172:192-198.
72. Vila-del Sol, V., M. Díaz-Muñoz, and M. Fresno. 2007. Requirement of tumor necrosis factor α and nuclear factor-κB in the induction by IFN-γ of inducible nitric oxide synthase in macrophages. J. Leukoc. Biol. 81:272-283.
73. Vonk, A. G., C. W. Wieland, M. G. Netea, and B. J. Kullberg. 2002. Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different microbiological test systems. J. Microbiol. Methods. 49:55-62.
74. Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.